Take a few minutes to catch up on the latest rheumatology news for the month of November 2022.
Personalizing non-pharmacological treatment for patients with fibromyalgia using a targeted symptom approach may improve outcomes.
"It may be important to identify genetic variants from a gout genome-wide association study (GWAS) rather than serum urate GWAS, in case these variants have an effect on gout independent of their effect on serum urate.”
Each year, the American College of Rheumatology (ACR) hosts an annual meeting that serves as one of the foremost opportunities for advancement and collaboration within the field of rheumatology. This year’s meeting, aptly named ACR 2022 Convergence, represents the first opportunity for many within the field to converge, collaborate, and celebrate the advances within the field together since 2019.
Investigators aimed to assess self-reported changes in physical activity during the COVID-19 pandemic.
Rheumatology Network interviewed Bahar Moghaddam, MD, Assistant Professor of Medicine in the Division of Rheumatology, Mount Sinai Health System, to discuss the impact of arthritis in the United States and worldwide, recent drug approvals, and the importance of early diagnosis and management of rheumatic diseases. Refresh your knowledge of arthritis with this professional insight.